The resources below are intended to harmonize site-level procedures and address issues of common concern among clinical research sites.
In March 2022, HANC hosted a two-part webinar series exploring the regulatory foundations and implementation of electronic informed consent in clinical trials. Webinar recordings and slides from the sessions can be found below and on the HANC Webinars & Presentations page:
The guidelines are intended to identify significant financial interests of network-affiliated researchers and avoid conflicts of interest, or the appearance of such conflicts, in activities of the networks. Network Leaders approved the guidelines on the April 2010 Network Leaders call and the document has been adopted as standard operating procedure for all networks effective April 15, 2010.
NIAID HIV/AIDS Clinical Trials Networks Financial Disclosure and COI Guidelines SOP
Version 11.0 of the “NIAID (DAIDS)-supported and/or Sponsored HIV/AIDS Clinical Trials Networks Financial Disclosure and Conflict of Interest Guidelines”.
Last updated May 23, 2022
Additional financial disclosure guidance for investigators can be found at the following sources:
National Institutes of Health (NIH) FDCOI Guidance
Food and Drug Administration (FDA) FDCOI Guidance
The following templates are provided to assist sites in developing CRS SOPs and meet the List of Required SOPs at DAIDS CRS.
Additional templates will be added as they become available.
Last updated May 23, 2022